Phase III trial of MVA 5T4 (TroVax) in patients with colorectal cancer (QUick And Simple And Reliable V).

Trial Profile

Phase III trial of MVA 5T4 (TroVax) in patients with colorectal cancer (QUick And Simple And Reliable V).

Planning
Phase of Trial: Phase III

Latest Information Update: 19 May 2011

At a glance

  • Drugs MVA 5T4 (Primary)
  • Indications Colorectal cancer
  • Focus Registrational; Therapeutic Use
  • Acronyms QUASAR-V
  • Most Recent Events

    • 19 May 2011 Planned initiation date changed from 1 Jul 2008 to 1 Dec 2011.
    • 13 Mar 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top